---
tags: [plan]
---

# Roadmap & Prioritization

**Last updated**: 2026-08-28 — after re-verification pass across all five startup ideas + the one general idea.

This file is the "what do I actually do, in what order" view. It doesn't replace each idea's own research file — it just ranks them and tells you where to spend the next block of hours. Full evidence lives in each idea's own `.md` file, linked below.

---

## Ranking (best to worst, right now)

1. **[[Startup Ideas/02 - Pathology Lab Ops Assistant/Pathology Lab Ops Assistant|Pathology Lab Ops Assistant]] — start here**
2. **[[Startup Ideas/03 - Ecommerce Hub/Ecommerce Hub|Ecommerce Hub]] — validate in parallel, don't build yet**
3. [[Startup Ideas/05 - Vertical Ops Assistant (Other Industries)/Vertical Ops Assistant (Other Industries)|Vertical Ops Assistant]] — dead for now, one speculative thread worth a future look
4. [[Startup Ideas/01 - AI Chatbot Assistant/AI Chatbot Assistant|AI Chatbot Assistant]] — dead, correctly already abandoned
5. [[Startup Ideas/04 - AI for Defence/AI for Defence|AI for Defence]] — can't be ranked, no description exists yet
6. [[General Ideas/01 - Algo Trading Bot/Algo Trading Bot|Algo Trading Bot]] — parked, not a current venture

---

## Why Pathology Lab Ops Assistant is #1

This is the only idea with three things stacked at once: a **working v0 prototype already built**, a **real willingness-to-pay signal from a real customer** (the family lab has agreed to ₹40,000 one-time + AMC — verified, not assumed), and a **genuine unfair advantage** (personal/family access to a real lab as design partner, which no competitor has). Re-verification this pass didn't change any of that.

The honest caveat, unchanged from Pass 5/6: the total addressable market is small (₹150–300 cr/year, ~4% growth) and several scrappy local vendors (Flabs, Labsmart, Attune, and cheap IndiaMART one-time-software sellers) already compete on price in this exact niche. This is **a real, buildable small business — not a venture-scale bet.** That's fine if the goal is "build something real and profitable now," not fine if the goal is "raise venture money."

**What "start here" means concretely**: the six lab interviews (beyond just the family lab) that were already planned in Pass 5, with kill criteria already set, have not been reported as done yet. That's the actual next action — not more desk research, not more building. Confirm real labs beyond your family's will actually pay before writing more code.

---

## Why Ecommerce Hub is #2, not #1

The product-side research is solid and done: there's a verified, real gap (no major global tool — Triple Whale, Polar, Northbeam, Rockerbox, Daasity, Glew — supports Razorpay or Indian logistics natively), and a clear closest competitor to study (BiteSpeed). But two separate search passes, including one using deliberately India-specific and colloquial phrasing, found **zero direct evidence of founders actually complaining about this pain publicly.** That doesn't mean the pain is fake — it may just be discussed in private WhatsApp/Slack groups search can't reach — but it means the idea is currently unvalidated on the demand side, in a way Pathology Lab isn't.

**What to actually do**: talk to 10–20 Indian D2C founders directly. This is cheap (conversations, not code) and can run in parallel with the Pathology Lab interviews. Do not start building this one until those conversations produce real evidence of the pain, ideally with a number attached (how much time/money it's costing them today).

---

## Why the rest are lower priority

- **Vertical Ops Assistant (CA/accounting, logistics, SME finance-ops)**: re-verified as still crowded — and actually got worse: Suvit was acquired by Vyapar in 2026 into a combined, funded incumbent. Not worth pursuing these three specific angles. One thread is worth remembering for later, purely speculative: diagnostic/imaging centers (radiology, dialysis chains) sit next to pathology labs and might offer a similar access-advantage pattern if Pathology Lab succeeds and you want to repeat the playbook — but this has had zero actual research, it's a guess.
- **AI Chatbot Assistant**: re-confirmed dead as a generic play — 2026 industry commentary is now even more unanimous that horizontal AI chatbots are being absorbed by ChatGPT/Claude/Gemini directly, with vertical, workflow-specific products being the only model that still works. This is exactly why the pivot to Pathology Lab happened, and that pivot logic holds.
- **AI for Defence**: still cannot be researched — there's no description on file of who pays, what it does, or why now. Either describe it in detail so it can get the same evidence-based teardown as the others, or treat it as inactive.
- **Algo Trading Bot**: this lives in "General Ideas," not "Startup Ideas," and is currently paper-trading/backtest only, not handling real money. Not being actively pursued as a venture right now — leave it parked unless you want to revisit it deliberately.

---

## Suggested order of operations

1. **This week**: run (or finish, if already started) the six pathology-lab interviews beyond the family lab. This has kill criteria already defined — if it fails those, the venture-scale version of this idea dies, but the "small real business" version may still be worth running just for the family lab's real ₹40k+AMC.
2. **In parallel**: start reaching out to 10–20 Indian D2C founders for the Ecommerce Hub validation. This costs time, not money — no reason to wait on step 1 to finish first.
3. **Decision point after both**: if Pathology Lab interviews confirm other labs will pay too, that's your primary build focus — it's the most de-risked idea on the list. If Ecommerce Hub founder conversations turn up real, specific, costly pain, that becomes a second serious track (larger market, but more competition and a harder validation bar than pathology).
4. **Don't spend more time on**: Vertical Ops Assistant's three researched candidates, or the generic AI Chatbot Assistant — both are settled, re-verified dead ends for now.
5. **Whenever you have 10 minutes**: write out what AI for Defence actually is (who pays, what it does, why now) so it can either get properly researched or be formally dropped instead of sitting as a permanent placeholder.

---

## Update — 2026-08-29: evolved AI Chatbot Assistant idea re-researched

Priyam described an evolved version of idea 01 (AI Chatbot Assistant): a simpler agent builder bundled with employee monitoring, insider-leak/DLP detection, and a private company-hosted AI, possibly packaged as an "OS." Researched properly — see [[Startup Ideas/01 - AI Chatbot Assistant/AI Chatbot Assistant|AI Chatbot Assistant]] Pass 3 for full detail.

**Verdict: 🔴 High risk, not recommended ahead of the current top two.** It bundles three separate markets: a crowded-but-narrow-wedge-viable agent-builder space (n8n, Gumloop, Dify, Chatbase already funded/profitable there), a genuinely hard enterprise DLP market requiring SOC2/ISO27001 and long sales cycles, and a capital-intensive private-AI-infra play ($150k-500k in GPU hardware for a mid-size company). Only the agent-builder UI layer is realistically buildable via vibe coding — the security/compliance/infra layers are not.

**Ranking is unchanged at the top**: Pathology Lab Ops Assistant is still #1, Ecommerce Hub still #2. This evolved idea ranks below both — it doesn't have Pathology Lab's working prototype + paying customer, and unlike Ecommerce Hub, it requires enterprise trust/security certification just to start selling, which a solo founder can't get to quickly. If pursued at all, the only defensible starting point within it is a narrow-niche personal/consumer agent tool (not the "OS" version), and even that lands in already-crowded territory.
